Skip to main content

Preclinical Development of GZ30-1, A Novel Chemoprotectant

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Nov 19, 2012
Award amount: 
$250,000
Organization name: 
G1 Therapeutics
Principal Investigator: 
Black, Claudia A
Grant program category: 
Business Financing
Grant program name: 
Strategic Growth Loan
Region: 
Research Triangle

G1 Therapeutics has discovered a novel small molecule-based method for preventing the hematological side effects of exposure to ionizing radiation and cancer chemotherapy. The Strategic Growth Loan will be used to help advance G1's lead chemoprotection compound toward clinical development."

Fiscal year: 
2013